Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2018

Open Access 01-12-2018 | Research article

Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial

Authors: Ana Paula Trussardi Fayh, Katiuce Borges, Giovani Santos Cunha, Mauricio Krause, Ricardo Rocha, Paulo Ivo Homem de Bittencourt Jr, José Cláudio Fonseca Moreira, Rogério Friedman, Juliane da Silva Rossato, Jõao Roberto Fernandes, Alvaro Reischak-Oliveira

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2018

Login to get access

Abstract

Background

The relationship between diabetes and oxidative stress has been previously reported. Exercise represents a useful non-pharmacological strategy for the treatment in type 2 diabetic (T2DM) patients, but high intensity exercise can induce a transient inflammatory state and increase oxidative stress. Nutritional strategies that may contribute to the reduction of oxidative stress induced by acute exercise are necessary. The aim of this study was to examine if n-3 PUFA supplementation intervention can attenuate the inflammatory response and oxidative stress associated with high intensity exercise in this population. As a primary outcome, lipoperoxidation measurements (TBARS and F2-isoprostanes) were selected.

Methods

Thirty T2DM patients, without chronic complications, were randomly allocated into two groups: placebo (gelatin capsules) or n-3 PUFA (capsules containing 180 mg of eicosapentaenoic acid and 120 mg of docosahexaenoic acid). Blood samples were collected fasting before and after 8 weeks supplementation. In the beginning and at the end of protocol, an acute exercise was performed (treadmill), and new blood samples were collected before and immediately after the exercise for measurements of oxidative stress and high-sensitivity C-reactive protein (hs-CRP).

Results

After the supplementation period, a decrease in triglycerides levels was observed only in n-3 PUFA supplementation group (mean difference and 95% CI of 0.002 (0.000–0.004), p = 0.005). Supplementation also significantly reduced TRAP levels after exercise (mean difference and 95% CI to 9641 (− 20,068–39,351) for − 33,884 (− 56,976 - -10,793), p = 0.004, Cohen’s d effect size = 1.12), but no significant difference was observed in n-3 PUFA supplementation group in lipoperoxidation parameters as TBARS (mean difference and 95% CI to − 3.8 (− 10–2.4) for − 2.9 (− 1.6–7.4) or F2-isoprostanes (mean difference and 95% CI -0.05 (− 0.19–0.10) for − 0.02 (− 0.19–0.16), p > 0.05 for both.

Conclusion

PUFA n-3 supplementation reduced triglycerides as well as TRAP levels after exercise, without a significant effect on inflammatory and oxidative stress markers.
This study is registered at ClinicalTrials.gov with the registration number of NCT03182712.
Literature
3.
go back to reference Newsholme P, et al. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond). 2009, 118(5):341–9. Newsholme P, et al. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond). 2009, 118(5):341–9.
4.
go back to reference Kesavulu MM, et al. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab. 2002;28(1):20–6.PubMed Kesavulu MM, et al. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab. 2002;28(1):20–6.PubMed
5.
go back to reference Peerapatdit T, et al. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus. J Med Assoc Thai. 2006;89(Suppl 5):S141–6.PubMed Peerapatdit T, et al. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus. J Med Assoc Thai. 2006;89(Suppl 5):S141–6.PubMed
6.
go back to reference Davi G, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 2003;107(25):3199–203.CrossRefPubMed Davi G, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 2003;107(25):3199–203.CrossRefPubMed
7.
go back to reference Davi G, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99(2):224–9.CrossRefPubMed Davi G, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99(2):224–9.CrossRefPubMed
8.
go back to reference Krause M, et al. The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production. Eur J Appl Physiol. 2013;114(2):251–60.CrossRef Krause M, et al. The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production. Eur J Appl Physiol. 2013;114(2):251–60.CrossRef
9.
go back to reference Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.CrossRefPubMed Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.CrossRefPubMed
10.
go back to reference Colberg SR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692–6.CrossRefPubMedPubMedCentral Colberg SR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692–6.CrossRefPubMedPubMedCentral
11.
go back to reference Fox CS, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.CrossRefPubMedPubMedCentral Fox CS, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.CrossRefPubMedPubMedCentral
12.
go back to reference Capo X, et al. Effects of almond- and olive oil-based Docosahexaenoic- and vitamin E-enriched beverage dietary supplementation on inflammation associated to exercise and age. Nutrients. 2016;8(10). Capo X, et al. Effects of almond- and olive oil-based Docosahexaenoic- and vitamin E-enriched beverage dietary supplementation on inflammation associated to exercise and age. Nutrients. 2016;8(10).
13.
go back to reference Chen C, et al. Association between omega-3 fatty acids consumption and the risk of type 2 diabetes: a meta-analysis of cohort studies. J Diabetes Investig. 2017;8(4):480–8.CrossRefPubMedPubMedCentral Chen C, et al. Association between omega-3 fatty acids consumption and the risk of type 2 diabetes: a meta-analysis of cohort studies. J Diabetes Investig. 2017;8(4):480–8.CrossRefPubMedPubMedCentral
14.
go back to reference Taghizadeh M, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Neurochem Int. 2017;108:183–9.CrossRefPubMed Taghizadeh M, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Neurochem Int. 2017;108:183–9.CrossRefPubMed
15.
go back to reference Mori TA, et al. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med. 2003;35(7):772–81.CrossRefPubMed Mori TA, et al. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med. 2003;35(7):772–81.CrossRefPubMed
16.
go back to reference Nalsen C, et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr. 2006;136(5):1222–8.CrossRefPubMed Nalsen C, et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr. 2006;136(5):1222–8.CrossRefPubMed
17.
go back to reference WHO, W.H.O.-. Obesity: preventing and managing the global epidemic. WHO, 2000. WHO, W.H.O.-. Obesity: preventing and managing the global epidemic. WHO, 2000.
18.
go back to reference Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978;40(3):497–504.CrossRefPubMed Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978;40(3):497–504.CrossRefPubMed
19.
go back to reference Siri WE. Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition. 1993;9(5):480–91. discussion 480, 492PubMed Siri WE. Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition. 1993;9(5):480–91. discussion 480, 492PubMed
20.
go back to reference Lucia A, et al. Heart rate and performance parameters in elite cyclists: a longitudinal study. Med Sci Sports Exerc. 2000;32(10):1777–82.CrossRefPubMed Lucia A, et al. Heart rate and performance parameters in elite cyclists: a longitudinal study. Med Sci Sports Exerc. 2000;32(10):1777–82.CrossRefPubMed
21.
go back to reference Midgley AW, et al. Criteria for determination of maximal oxygen uptake: a brief critique and recommendations for future research. Sports Med. 2007;37(12):1019–28.CrossRefPubMed Midgley AW, et al. Criteria for determination of maximal oxygen uptake: a brief critique and recommendations for future research. Sports Med. 2007;37(12):1019–28.CrossRefPubMed
22.
go back to reference Rodrigues-Krause J, et al. Oxygen consumption and heart rate responses to isolated ballet exercise sets. J Dance Med Sci. 2014;18(3):99–105.CrossRefPubMed Rodrigues-Krause J, et al. Oxygen consumption and heart rate responses to isolated ballet exercise sets. J Dance Med Sci. 2014;18(3):99–105.CrossRefPubMed
23.
go back to reference Ribeiro JP, et al. Metabolic and ventilatory responses to steady state exercise relative to lactate thresholds. Eur J Appl Physiol Occup Physiol. 1986;55(2):215–21.CrossRefPubMed Ribeiro JP, et al. Metabolic and ventilatory responses to steady state exercise relative to lactate thresholds. Eur J Appl Physiol Occup Physiol. 1986;55(2):215–21.CrossRefPubMed
24.
go back to reference Valk EE, Hornstra G. Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review. Int J Vitam Nutr Res. 2000;70(2):31–42.CrossRefPubMed Valk EE, Hornstra G. Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review. Int J Vitam Nutr Res. 2000;70(2):31–42.CrossRefPubMed
25.
go back to reference Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMed Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMed
26.
go back to reference Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–31.CrossRefPubMed Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–31.CrossRefPubMed
27.
go back to reference Lissi E, et al. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med. 1995;18(2):153–8.CrossRefPubMed Lissi E, et al. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med. 1995;18(2):153–8.CrossRefPubMed
28.
go back to reference Bannister JV, Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal. 1987;32:279–312.PubMed Bannister JV, Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal. 1987;32:279–312.PubMed
29.
go back to reference Lowry OH, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed Lowry OH, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed
30.
go back to reference Ortenblad N, Madsen K, Djurhuus MS. Antioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans. Am J Phys. 1997;272(4 Pt 2):R1258–63. Ortenblad N, Madsen K, Djurhuus MS. Antioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans. Am J Phys. 1997;272(4 Pt 2):R1258–63.
31.
go back to reference Laaksonen DE, et al. Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care. 1996;19(6):569–74.CrossRefPubMed Laaksonen DE, et al. Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care. 1996;19(6):569–74.CrossRefPubMed
32.
go back to reference Atalay M, et al. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand. 1997;161(2):195–201.CrossRefPubMed Atalay M, et al. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand. 1997;161(2):195–201.CrossRefPubMed
33.
go back to reference Davison GW, et al. Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radic Biol Med. 2002;33(11):1543–51.CrossRefPubMed Davison GW, et al. Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radic Biol Med. 2002;33(11):1543–51.CrossRefPubMed
34.
go back to reference Accinni R, et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis. 2006;16(2):121–7.CrossRefPubMed Accinni R, et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis. 2006;16(2):121–7.CrossRefPubMed
35.
go back to reference Smaoui M, et al. Association between dietary fat and antioxidant status of Tunisian type 2 diabetic patients. Prostaglandins Leukot Essent Fatty Acids. 2006;74(5):323–9.CrossRefPubMed Smaoui M, et al. Association between dietary fat and antioxidant status of Tunisian type 2 diabetic patients. Prostaglandins Leukot Essent Fatty Acids. 2006;74(5):323–9.CrossRefPubMed
36.
go back to reference Erdogan H, et al. Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostaglandins Leukot Essent Fatty Acids. 2004;71(3):149–52.CrossRefPubMed Erdogan H, et al. Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostaglandins Leukot Essent Fatty Acids. 2004;71(3):149–52.CrossRefPubMed
37.
go back to reference Laaksonen DE, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403–10.CrossRefPubMed Laaksonen DE, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403–10.CrossRefPubMed
38.
go back to reference Pradhan AD, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–34.CrossRefPubMed Pradhan AD, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–34.CrossRefPubMed
39.
go back to reference Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006;75(3):197–202.CrossRefPubMed Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006;75(3):197–202.CrossRefPubMed
40.
go back to reference Madsen T, et al. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr. 2003;89(4):517–22.CrossRefPubMed Madsen T, et al. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr. 2003;89(4):517–22.CrossRefPubMed
41.
go back to reference Azizi-Soleiman F, et al. Effects of pure eicosapentaenoic and docosahexaenoic acids on oxidative stress, inflammation and body fat mass in patients with type 2 diabetes. Int J Prev Med. 2013;4(8):922–8.PubMedPubMedCentral Azizi-Soleiman F, et al. Effects of pure eicosapentaenoic and docosahexaenoic acids on oxidative stress, inflammation and body fat mass in patients with type 2 diabetes. Int J Prev Med. 2013;4(8):922–8.PubMedPubMedCentral
42.
go back to reference Hendra TJ, et al. Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care. 1990;13(8):821–9.CrossRefPubMed Hendra TJ, et al. Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care. 1990;13(8):821–9.CrossRefPubMed
43.
go back to reference Petersen M, et al. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. Diabetes Care. 2002;25(10):1704–8.CrossRefPubMed Petersen M, et al. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. Diabetes Care. 2002;25(10):1704–8.CrossRefPubMed
44.
go back to reference Rivellese AA, et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996;19(11):1207–13.CrossRefPubMed Rivellese AA, et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996;19(11):1207–13.CrossRefPubMed
45.
go back to reference Luo J, et al. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care. 1998;21(5):717–24.CrossRefPubMed Luo J, et al. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care. 1998;21(5):717–24.CrossRefPubMed
46.
go back to reference Mansoori A, et al. Effect of DHA-rich fish oil on PPARgamma target genes related to lipid metabolism in type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Lipidol. 2015;9(6):770–7.CrossRefPubMed Mansoori A, et al. Effect of DHA-rich fish oil on PPARgamma target genes related to lipid metabolism in type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Lipidol. 2015;9(6):770–7.CrossRefPubMed
47.
go back to reference Moore CS, et al. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition. 2006;22(10):1012–24.CrossRefPubMed Moore CS, et al. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition. 2006;22(10):1012–24.CrossRefPubMed
48.
go back to reference Hartweg J, et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia. 2007;50(8):1593–602.CrossRefPubMed Hartweg J, et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia. 2007;50(8):1593–602.CrossRefPubMed
49.
go back to reference Abe Y, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18(5):723–31.CrossRefPubMed Abe Y, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18(5):723–31.CrossRefPubMed
50.
go back to reference Mostad IL, et al. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus. Metabolism. 2009;58(12):1753–61.CrossRefPubMed Mostad IL, et al. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus. Metabolism. 2009;58(12):1753–61.CrossRefPubMed
Metadata
Title
Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial
Authors
Ana Paula Trussardi Fayh
Katiuce Borges
Giovani Santos Cunha
Mauricio Krause
Ricardo Rocha
Paulo Ivo Homem de Bittencourt Jr
José Cláudio Fonseca Moreira
Rogério Friedman
Juliane da Silva Rossato
Jõao Roberto Fernandes
Alvaro Reischak-Oliveira
Publication date
01-12-2018
Publisher
BioMed Central
DOI
https://doi.org/10.1186/s12970-018-0222-2

Other articles of this Issue 1/2018

Journal of the International Society of Sports Nutrition 1/2018 Go to the issue